ENTITY
stringlengths 8
8
| DEFINITION
stringlengths 3
8.47k
⌀ | ALIASES
stringlengths 2
13.6k
⌀ | NAME
stringlengths 2
1.98k
|
|---|---|---|---|
C1332661 | This gene is involved in the activation of apoptosis. | CASPASE 10, APOPTOSIS-RELATED CYSTEINE PROTEASE|FLICE2|caspase 10|FADD-LIKE ICE 2|CASP10|CASP10B|MCH4|CASP10 Gene|CASPASE 10, ISOFORM B|CASP10 gene|Caspase 10, Apoptosis-Related Cysteine Peptidase Gene | CASP10 gene |
C1332661 | This gene is involved in the activation of apoptosis. | CASPASE 10, APOPTOSIS-RELATED CYSTEINE PROTEASE|FLICE2|caspase 10|FADD-LIKE ICE 2|CASP10|CASP10B|MCH4|CASP10 Gene|CASPASE 10, ISOFORM B|CASP10 gene|Caspase 10, Apoptosis-Related Cysteine Peptidase Gene | CASP10 gene |
C0016431 | The fluid surrounding the OVUM and GRANULOSA CELLS in the Graafian follicle (OVARIAN FOLLICLE). The follicular fluid contains sex steroids, glycoprotein hormones, plasma proteins, mucopolysaccharides, and enzymes. | Liquor follicularis|Antral Fluid, Ovarian Follicle|Folliculi, Liquor|fluid follicular|Portion of follicular fluid|Liquor folliculi|Follicular fluid|Liquor Folliculi|Follicular Fluids|Fluid, Follicular|follicular fluid | Follicular Fluid |
C0154208 | null | Disorder of endocrine ovary (disorder)|Ovarian dysfunction, NOS|DYSFUNCTION OVARIAN|Ovarian dysfunction|Disorder of endocrine ovary, NOS|Ovarian Dysfunction|DISORDERS OF THE ENDOCRINE OVARIES|Unspecified ovarian dysfunction | Disorder of endocrine ovary |
C0676461 | null | null | PIN protocol |
C0232896 | Condition of the genital organs and breasts and the ability to reproduce. | functions reproductive|function reproductive|reproductive function|FUNCTIONS OF REPRODUCTION|Reproductive function (observable entity)|reproduction function|Reproductive function | Reproductive function |
C1512575 | DNA sequences in a gene's promoter region that mediate expression during hypoxia. Since unlike normal tissues, solid tumors frequently have regions of hypoxia, suicide genes controlled by hypoxia-responsive elements may provide a means for cancer-specific gene therapy. | null | Hypoxia-Responsive Elements |
C0009637 | In biology, the beginning of pregnancy, marked by fertilization of an egg by a sperm. | Conception|Conception, function|conception|biological conception|conceptions|Conceptions|Conception, function (observable entity) | Conception |
C0021054 | Biologically active substances whose activities affect or play a role in the functioning of the immune system. | Factors, Immunologic|immunologic substance|Immunologic Factors|Immunological Factors|Factors, Immunological|Immunologic substance (substance)|immunological substance|Immunologic Factor|Immune Factors|Factors, Immune|Immunologic substance|immunologic factors | Immunologic Factors |
C1415534 | This gene is involved in growth factor processing. | HGFAP|HEPATOCYTE GROWTH FACTOR ACTIVATOR|HGF Activator Gene|HGF ACTIVATOR|HGFA|HGFAC Gene|HGFAC gene|HGFAC|HGF activator | HGFAC gene |
C1415534 | This gene is involved in growth factor processing. | HGFAP|HEPATOCYTE GROWTH FACTOR ACTIVATOR|HGF Activator Gene|HGF ACTIVATOR|HGFA|HGFAC Gene|HGFAC gene|HGFAC|HGF activator | HGFAC gene |
C0333442 | null | Hydropic change|Hydropic Change|Degeneration, liquefactive|molar degeneration|Colliquative degeneration|Hydropic degeneration|Degeneration, hydropic|Hydatidiform degeneration|Molar degeneration|Hydropic degeneration (disorder)|Liquefactive degeneration|hydropic degeneration|Hydropic degeneration (morphologic abnormality)|changes hydropic|hydropic change | Hydropic degeneration |
C0333902 | An increase in the size of a cellular nucleus. | Nuclear enlargement|KARYOMEGALY|Megalokaryosis|Macronucleus|Karyomegaly|Nuclear Enlargement|Macronucleus (morphologic abnormality) | Karyomegaly |
C0020809 | An alcohol oxidoreductase which catalyzes the oxidation of L-iditol to L-sorbose in the presence of NAD. It also acts on D-glucitol to form D-fructose. It also acts on other closely related sugar alcohols to form the corresponding sugar. EC 1.1.1.14 | Sorbitol dehydrogenase|2-Dehydrogenase, L-Iditol|polyol dehydrogenase|L-iditol dehydrogenase|sorbitol dehydrogenase|Dehydrogenase, Sorbitol|Dehydrogenase, Iditol|L-Iditol 2-Dehydrogenase|L-Iditol dehydrogenase|Iditol Dehydrogenase|L-iditol 2-dehydrogenase|Sorbital dehydrogenase|Sorbitol Dehydrogenase|L iditol dehydrogenase|L-iditol 2-dehydrogenase (substance)|Dehydrogenase, Polyol|L Iditol 2 Dehydrogenase|Polyol Dehydrogenase|Polyol dehydrogenase|L-Iditol:NAD+ 2-oxidoreductase | L-Iditol 2-Dehydrogenase |
C0872187 | Use of robots and other automated techniques to screen large numbers of samples. | high throughput screening|High Throughput Assay | High Throughput Screening |
C0430389 | Light Microscopy is a technique for producing visible images of structures or details which are too small to be otherwise seen by the human eye. It involves passing light transmitted through or reflected from the subject through a series of lenses to be detected directly by the eye, imaged on a photographic plate, or captured digitally. | Light microscopy (procedure)|Hand-Held Microscopy|Optical Microscopy|Light microscopy technique (qualifier value)|Light microscopy|Light microscopy technique|Microscopy, Optical|Light microscopy, NOS|Observation by light microscope, NOS|Hand Held Microscopy|Microscopy, Hand-Held|Microscopy, Compound|Observation by light microscope|LM - Light microscopy|LIGHT MICROSCOPY|Microscopy, Light|Microscopy, Simple|light microscopy|Light Microscopy|Compound Microscopy|Simple Microscopy | Light Microscopy |
C1449562 | The initial culturing of cells derived directly from fresh TISSUES. | Culturing, in vitro Vertebrate, Primary|Primary Cell Cultures|Cell Culture, Primary|Cell Cultures, Primary|Primary Cell Culture | Primary Cell Culture |
C0007022 | A solvent for oils, fats, lacquers, varnishes, rubber waxes, and resins, and a starting material in the manufacturing of organic compounds. Poisoning by inhalation, ingestion or skin absorption is possible and may be fatal. (Merck Index, 11th ed) | carbon tetrachloride|CARBON TETRACHLORIDE|Methane, tetrachloro-|Perchloromethane|Tetrachloride, Carbon|Tetrachloromethane|Carbon tetrachloride (substance)|Carbon tetrachloride|Carbon Tet|Carbon Tetrachloride|ccl4|Carbon Chloride | Carbon Tetrachloride |
C0039644 | A naphthacene antibiotic that inhibits AMINO ACYL TRNA binding during protein synthesis. | (4S,4aS,5aS,12aS)-4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide|Tetracyclin|Tetracycline|tetracycline|Tetrazyklin|Tétracycline|Tetracycline (substance)|Tsiklomitsin|Tetracycline-containing product|TCN|2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, (4S-(4alpha,4aalpha,5aalpha,6beta,12aalpha))-|Tetracycline, NOS|TETRACYCLINE|Tetracyclinum|Product containing tetracycline (medicinal product)|4-(Dimethylamino)-1,4,4A,5,5A,6,11,12A-Octahydro-3,6,10,12,12A-Pentahydroxy-6-Methyl-1,11-Dioxo-2-Naphthacenecarboxamide | tetracycline |
C0183396 | An instrument that determines the exact mass of charged particles or ions by measuring the flight path through a set of magnetic and electric fields. | Mass Spectrometer|mass spectrometer|MASS SPECTROMETER, CLINICAL USE|MS | Mass Spectrometers (device) |
C0205107 | Situated nearest to a point of attachment or origin. | neighboring|Nearest|PROXIMAL|Proximal (qualifier value)|Near to|Proximal|Neighbor of|Neighbour of|proximal | Proximal |
C0242349 | A method for the detection of proteins or antigens on samples of cells that are grown in monolayers or in suspension and deposited on slides using antibodies or other biomolecules that bind the target and can be visualized through a chemical process. | immunocytochemistry|Immunocytochemical procedure (procedure)|Immunocytochemistry test|Immunocytochemistry|ICC|Immunocytochemistry test (procedure)|Immunocytochemical procedure | Immunocytochemistry |
C0596763 | Toxicity that impairs or damages the immune system. | immunotoxicity|Immunotoxicity|toxic reaction in immunology | Immunotoxicity |
C1516635 | Actual observation and treatment of disease in patients (including experimental treatment) as distinct from theoretical or experimental work. | null | Clinical Treatment |
C0003753 | An alkaloid obtained from the betel nut (Areca catechu), fruit of a palm tree. It is an agonist at both muscarinic and nicotinic acetylcholine receptors. It is used in the form of various salts as a ganglionic stimulant, a parasympathomimetic, and a vermifuge, especially in veterinary practice. It has been used as a euphoriant in the Pacific Islands. | arecholin|Methylarecaidin|arecholine|Arecholin|methylarecaidin|arecoline|arecolin|Arecholine|arecaline|Arecoline (substance)|ARECOLINE|Arecaline|Arecoline|3-Pyridinecarboxylic acid, 1,2,5,6-tetrahydro-1-methyl-, methyl ester|arecoline in any form|Arecolin | Arecoline |
C1565860 | An enzyme that speeds up the formation of substances that cause inflammation and pain. It may also cause tumor cells to grow. Some tumors have high levels of COX-2 and blocking its activity may reduce tumor growth. | Cyclooxygenase 2|Glucocorticoid-Regulated Inflammatory Prostaglandin G/H Synthase|Prostaglandin G/H Synthase 2|PHS II|PTGS2 protein, human|Prostaglandin H2 Synthase 2|COX-2|prostaglandin-endoperoxide synthase 2 (prostaglandin G-H synthase and cyclooxygenase), human|Prostaglandin-Endoperoxide Synthase|PGHS2|prostaglandin-endoperoxide synthase 2|COX-2 prostaglandin synthase, human|Prostaglandin G/H Synthase and Cyclooxygenase|Cyclooxygenase-2|PGHS-2|COX2|PTGS2|COX2 prostaglandin synthase, human|Cyclo-Oxygenase-2|PTGS|EC 1.14.99.1|PGH Synthase 2|Prostaglandin-Endoperoxide Synthase 2|cyclooxygenase-2|Cyclooxygenase | PTGS2 protein, human |
C0026682 | High molecular weight mucoproteins that protect the surface of EPITHELIAL CELLS by providing a barrier to particulate matter and microorganisms. Membrane-anchored mucins may have additional roles concerned with protein interactions at the cell surface. | mucin|Mucus Glycoprotein|Mucin-containing product|Mucins|Mucin|Product containing mucin (medicinal product)|Mucin (substance)|mucins | mucins |
C0022790 | Mucocellular carcinoma of the ovary, usually metastatic from the gastrointestinal tract, characterized by areas of mucoid degeneration and the presence of signet-ring-like cells. It accounts for 30%-40% of metastatic cancers to the ovaries and possibly 1%-2% of all malignant ovarian tumors. The lesions may not be discovered until the primary disease is advanced, and most patients die of their disease within a year. In some cases, a primary tumor is not found. (From Dorland, 27th ed; Holland et al., Cancer Medicine, 3d ed, p1685) | Krukenberg tumor (disorder)|Carcinoma, Krukenberg|Krukenberg tumour|Secondary tumour to ovary|Secondary tumor to ovary|Secondary malignant neoplasm of ovary (disorder)|Krukenbergs Tumor|Ovarian metastasis|Krukenburg tumour|krukenberg's tumor|Tumor, Krukenberg's|Krukenberg Tumor|Tumor, Krukenberg|Secondary malignant neoplasm of ovary|Cancer metastatic to ovary|Krukenberg tumor|Krukenberg's Tumor|Krukenberg Carcinoma|Krukenburg tumor|Secondary cancer of ovary|krukenberg tumor|Metastatic malignant neoplasm to ovary|Krukenberg Neoplasm|krukenburg tumor|Metastasis to ovary | Krukenberg Tumor |
C0205697 | A malignant epithelial neoplasm characterized by the presence of spindle cells and anaplastic morphologic features. Giant cells and a sarcomatous component may also be present. | Spindle-Cell Carcinomas|Spindle-Cell Carcinoma|Pseudosarcomatous carcinoma (morphologic abnormality)|Spindle Cell Carcinoma|sarcomatoid carcinoma|CARCINOMA, SPINDLE CELL, MALIGNANT|Polypoid squamous cell carcinoma|Sarcomatoid carcinoma|Spindle cell carcinoma|Carcinoma, Spindle Cell|Pseudosarcomatous carcinoma|Spindle cell carcinoma (morphologic abnormality)|spindle-cell carcinoma|Pseudosarcomatous Carcinoma|spindle cell carcinoma|Sarcomatoid Carcinoma | Carcinoma, Spindle-Cell |
C0228492 | null | Hemispheral lobule VI|Lobulus simplex|Posterior quadrangular lobule|Structure of posterior semilunar lobule|Posterior quadrangular lobule of cerebellum|Posterior lunate lobule|Structure of posterior semilunar lobule (body structure)|Posterior semilunar lobule|Posterior quadrangular lobule of cerebellum [H VI] | Posterior semilunar lobule |
C0346210 | Intraepithelial neoplasia of the vulvar squamous epithelium. There is no evidence of invasion. This category includes vulvar high grade squamous intraepithelial lesion and vulvar intraepithelial neoplasia, differentiated type. | vulval dysplasia|vulvar intraepithelial neoplasia|dysplasia of the vulva|Dysplasia of vulva (disorder)|Vulval intraepithelial neoplasia (disorder)|Squamous Vulvar Intraepithelial Neoplasia|vulva intraepithelial neoplasia|vulval intraepithelial neoplasia|Vulvar intraepithelial neoplasia|carcinoma situ vulva|Intraepithelial Neoplasia of Vulva|vin|cancer situ vulvar|intraepithelial neoplasia of vulva|VIN|vulva dysplasia|Vulva Intraepithelial Neoplasia|Vulval Intraepithelial Neoplasia|Vulval intraepithelial neoplasia|Intraepithelial Neoplasia of the Vulva|Dysplasia of vulva|dysplasia of vulva|Vulval intraepithelial neoplasia (VIN)|vulvar dysplasia|vulvar cancer in situ|Vulvar Intraepithelial Neoplasia|intraepithelial neoplasia of the vulva|dysplasia vulvar | Vulval intraepithelial neoplasia |
C0432487 | A condition in which a group of B-cells grow out of control after an organ transplant in patients with weakened immune systems. This usually happens if the patient has also been infected with Epstein-Barr virus. Post-transplant lymphoproliferative disorder may progress to non-Hodgkin lymphoma. | post-transplant lymphoproliferative disorder|Post-transplant lymphoproliferative disorder (PTLD)|Post-transplantation lymphoproliferative syndrome|Post-transplant lymphoproliferative disorder|Post transplant lymphoproliferative disorder, no International Classification of Diseases for Oncology subtype|Post transplant lymphoproliferative disorder|Lymphoproliferative disorder following transplantation (disorder)|Post transplant lymphoproliferative disorder, no ICD-O subtype|PTLD|Post transplant lymphoproliferative disorder, no International Classification of Diseases for Oncology subtype (morphologic abnormality)|PTLD - Post-transplant lymphoproliferative disorder|Lymphoproliferative disorder following transplantation|Post-Transplant Lymphoproliferative Disorder|Post-transplant Lymphoproliferative Disorder | Post-transplant lymphoproliferative disorder |
C0935850 | The injection of umbilical cord blood to restore an individual's own blood production system suppressed by anticancer drugs, radiation therapy, or both. It is being studied in the treatment of cancer and severe blood disorders such as aplastic anemia. Cord blood contains high concentrations of stem cells needed to produce new blood cells. | transplantation, umbilical cord blood|UCB transplantation|cord blood transplantation|Umbilical Cord Blood Transplantation|Cord Blood Transplantation|umbilical cord blood transplantation | Umbilical Cord Blood Transplantation |
C0005954 | A procedure in which a small sample of bone with bone marrow inside it is removed, usually from the hip bone. A small area of skin and the surface of the bone underneath are numbed with an anesthetic. Then, a special, wide needle is pushed into the bone and rotated to remove a sample of bone with the bone marrow inside it. The sample is sent to a laboratory to be looked at under a microscope. This procedure may be done at the same time as a bone marrow aspiration. | Biopsy of bone marrow|Biopsy of Bone Marrow|Bone marrow sampling|Bone marrow sampling (procedure)|Biopsy, Bone Marrow|marrow biopsy|Bone Marrow Biopsy|Bone marrow biopsy|biopsy marrow|biopsies bone marrow|bone marrow biopsy|biopsy bone marrow|of bone marrow biopsy|biopsy of bone marrow | Bone marrow biopsy |
C1334798 | A clonal lymphoproliferative disorder arising as a result of post-transplant immunosuppression therapy. It is characterized by destructive infiltration of lymph nodes and extranodal sites by a monotonous population of transformed lymphocytes or plasma cells. It includes two variants: monomorphic B-cell and monomorphic T/NK cell post-transplant lymphoproliferative disorders. | Post-transplant lymphoproliferative disorder (Monoclonal), NOS|Monomorphic PTLD|PTLD (Monoclonal) | Monomorphic Post-Transplant Lymphoproliferative Disorder |
C1301361 | A clonal B-cell lymphoproliferative disorder arising as a result of post-transplant immunosuppression therapy. It is characterized by destructive infiltration of lymph nodes and extranodal sites by a polymorphic B-cell infiltrate composed of small and medium sized lymphocytes, immunoblasts, and plasma cells. In some cases, reduction of the immunosuppression therapy may lead to regression of the lesions. In other cases the lesions may progress to lymphoma. | Polymorphic PTLD|Polymorphic lymphoproliferative disorder following transplant|Post-transplant lymphoproliferative disorder, polymorphic (morphologic abnormality)|Polymorphic lymphoproliferative disorder following transplant (disorder)|Polymorphic B-Cell Lymphoma|Polymorphic Post-Transplant Lymphoproliferative Disorder|Polymorphic post-transplant lymphoproliferative disorder | Post-transplant lymphoproliferative disorder, polymorphic |
C0023043 | null | Antigen, Large T|T-Antigen, Large|Large T Antigen|T Antigen, Large | Large T-Antigen |
C0010819 | The study of the structure, behavior, growth, reproduction, and pathology of cells; and the function and chemistry of cellular components. | cell biology|Biology, Cell|Cell Biologies|cellular biology|Cellular Biologies|Biology, Cellular|cytology (field)|biology cell|Cellular Biology|Biologies, Cell|Cell Biology|cytology field|cytology|Biologies, Cellular|Cytology | Cytology |
C0023043 | null | Antigen, Large T|T-Antigen, Large|Large T Antigen|T Antigen, Large | Large T-Antigen |
C0597032 | Cells of, or derived from, a tumor. | cells neoplastic|neoplastic cell|Tumor Cell|Neoplastic Cell | Neoplastic Cell |
C0040380 | A phenothiazine that has been used as a hemostatic, a biological stain, and a dye for wool and silk. Tolonium chloride has also been used as a diagnostic aid for oral and gastric neoplasms and in the identification of the parathyroid gland in thyroid surgery. | Toluidine Blue O|Blue, Toluidine|Phenothiazin-5-ium, 3-amino-7-(dimethylamino)-2-methyl-, chloride|blue toluidine|toluidine blue|Toluidine blue stain|Tolonium chloride-containing product|tolonium chloride|Toluidine blue|Blue O, Toluidine|TOLUIDINE BLUE|Product containing tolonium chloride (medicinal product)|Tolonium chloride (substance)|Tolonium chloride|TOLONIUM CHLORIDE|Toluidine blue O|3-Amino-7-Dimethylamino-2-Methylphenazathionium Chloride|Tolonium Chloride|Chloride, Tolonium|Toluidine Blue | tolonium chloride |
C0018964 | A dye obtained from the heartwood of logwood (Haematoxylon campechianum Linn., Leguminosae) used as a stain in microscopy and in the manufacture of ink. | Hemotoxylin|Benz(b)indeno(1,2-d)pyran-3,4,6a,9,10(6H)-pentol, 7,11b-dihydro-, cis-(+)-|Hematoxylin stain|Hydroxybrazilin|HEMATOXYLIN|Hematoxiline|hematoxiline|Hydroxybrasilin|Natural black 1|Hematoxylin stain (substance)|Hematoxylin|Natural Black 1|Haematoxylin stain|hematoxylin stain|haematoxylin|hemotoxylin|hematoxylin|Haematoxylin | Hematoxylin |
C0029005 | Proteins coded by oncogenes. They include proteins resulting from the fusion of an oncogene and another gene (ONCOGENE PROTEINS, FUSION). | ONCOGENE PROTEINS|Product, Oncogene|Oncoproteins|Oncogene Proteins|Proteins, Oncogene|Oncogene Products|Oncogene protein, NOS|Oncogene protein product, NOS|Oncogene protein|Oncogene Protein|Oncogene Product|oncoprotein|oncogene proteins|Protein, Oncogene|Oncogene protein (substance)|Products, Oncogene|Oncoprotein, NOS|Oncoprotein|oncoproteins | Oncogene Proteins |
C0039738 | A heavy, bluish white metal, atomic number 81, atomic weight [204.382; 204.385], symbol Tl. | Th|Thallium 205|Thallium Metallicum|Thallium-205|Tl|THALLIUM|Thallium (substance)|Thallium|Tl element|Tl - Thallium|thallium|Thallium, NOS | thallium |
C0029005 | Proteins coded by oncogenes. They include proteins resulting from the fusion of an oncogene and another gene (ONCOGENE PROTEINS, FUSION). | ONCOGENE PROTEINS|Product, Oncogene|Oncoproteins|Oncogene Proteins|Proteins, Oncogene|Oncogene Products|Oncogene protein, NOS|Oncogene protein product, NOS|Oncogene protein|Oncogene Protein|Oncogene Product|oncoprotein|oncogene proteins|Protein, Oncogene|Oncogene protein (substance)|Products, Oncogene|Oncoprotein, NOS|Oncoprotein|oncoproteins | Oncogene Proteins |
C1123009 | The differentiation of endothelial cells from progenitor cells during blood vessel development, and the de novo formation of blood vessels and tubes. [PMID:8999798] | vasculogenesis|vascular morphogenesis | vasculogenesis |
C0333271 | The leaking of serosanguinous fluids from an orifice or wound. | bloody discharge|discharge bloody|Bloody discharge|Discharge, bloody|Bloody discharge (morphologic abnormality)|Bloody Discharge|bloody drainage|Bloody Drainage | Bloody discharge finding |
C0279672 | An adenocarcinoma arising from the cervical epithelium. It accounts for approximately 15% of invasive cervical carcinomas. Increased numbers of sexual partners and human papillomavirus (HPV) infection are risk factors. Grossly, advanced cervical adenocarcinoma may present as an exophytic mass, an ulcerated lesion, or diffuse cervical enlargement. Microscopically, the majority of cervical adenocarcinomas are of the endocervical (mucinous) type. | Adenocarcinoma of the Uterine Cervix|Adenocarcinoma cervix uteri|uterine cervix cancer, adenocarcinoma|adenocarcinoma cervix|Adenocarcinoma - cervix|adenocarcinomas cervical|Adenocarcinoma of Uterine Cervix|cervix cancer, adenocarcinoma|adenocarcinoma of the cervix|Adenocarcinoma of the cervix|cervical cancer, adenocarcinoma|Cervix Uteri Adenocarcinoma|cervical adenocarcinoma|Cervix Adenocarcinoma|Adenocarcinoma of the Cervix Uteri|Adenocarcinoma of Cervix|adenocarcinoma of cervix|Adenocarcinoma of the Cervix|adenocarcinomas cervix|Adenocarcinoma of Cervix Uteri|Adenocarcinoma of cervix (disorder)|Adenocarcinoma|adenocarcinoma cervical cancer|Uterine Cervix Adenocarcinoma|Cervical Adenocarcinoma, Not Otherwise Specified|Cervical Adenocarcinoma|cervix adenocarcinoma|Adenocarcinoma of cervix|Cervical Adenocarcinoma, NOS | Cervical Adenocarcinoma |
C0004799 | A darkly stained mat-like EXTRACELLULAR MATRIX (ECM) that separates cell layers, such as EPITHELIUM from ENDOTHELIUM or a layer of CONNECTIVE TISSUE. The ECM layer that supports an overlying EPITHELIUM or ENDOTHELIUM is called basal lamina. Basement membrane (BM) can be formed by the fusion of either two adjacent basal laminae or a basal lamina with an adjacent reticular lamina of connective tissue. BM, composed mainly of TYPE IV COLLAGEN; glycoprotein LAMININ; and PROTEOGLYCAN, provides barriers as well as channels between interacting cell layers. | Membrana basalis|basement membrane|Basement Membrane|Basement membrane, NOS|membrane basement|Basement membrane (body structure)|Membranes, Basement|Membrane, Basement|Basement Membranes|Basement membrane|basement membranes|Basement membrane of connective tissue | Basement membrane |
C0020699 | Excision of the uterus. | hysterectomies|hysterectomy procedure|Hysterectomies|Hysterectomy|hysterectomy|Uterus excision|Hysterectomy (procedure)|hysterectomy procedures|Excision procedure on uterus|Hysterectomy NOS|Hysterectomy, NOS | Hysterectomy |
C0242939 | Radiotherapy given to augment some other form of treatment such as surgery or chemotherapy. Adjuvant radiotherapy is commonly used in the therapy of cancer and can be administered before or after the primary treatment. | adjuvant radiotherapy|Adjuvant Radiotherapies|Adjuvant Radiotherapy|Radiotherapies, Adjuvant | Radiotherapy, Adjuvant |
C0333241 | null | Chronic edema (morphologic abnormality)|Chronic edema|Chronic oedema | Chronic edema |
C0036095 | Tumors or cancer of the SALIVARY GLANDS. | salivary gland tumor|Gland Neoplasms, Salivary|Neoplasm of salivary gland (disorder)|Tumor of salivary gland|Salivary Gland Neoplasm|salivary gland neoplasm|Tumor of Salivary Gland|Neoplasm of the Salivary Gland|Tumour of salivary gland|Salivary gland neoplasm|Gland Neoplasm, Salivary|Neoplasm of salivary gland|Tumor of the Salivary Gland|gland salivary tumors|gland salivary tumours|glands salivary tumors|Salivary Gland Tumor|tumor salivary gland|glands neoplasms salivary|Neoplasm, Salivary Gland|glands salivary tumours|Salivary Gland Neoplasms|Neoplasm of Salivary Gland|Neoplasms, Salivary Gland|gland salivary tumor|Salivary gland neoplasia|salivary gland tumour | Salivary Gland Neoplasms |
C0018552 | A focal malformation resembling a neoplasm, composed of an overgrowth of mature cells and tissues that normally occur in the affected area. | hamartomas|hamartoma|HAMARTOMA|Hamartomatous|Hamartoma (morphologic abnormality)|hamartomatous|Hamartoma (disorder)|HAMARTOMAS|Hamartoma, NOS|Hamartoma|Hamartomas | Hamartoma |
C0027070 | A usually benign tumor made up predominantly of myoepithelial cells. | myoepithelioma|Tumor, Myoepithelial|Myoepitheliomas|Myoepithelioma|Myoepithelial Neoplasm|Myoepithelioma (morphologic abnormality)|myoepithelial tumor|Myoepithelial Tumors|Myoepithelial adenoma|Myoepithelial tumor|Tumors, Myoepithelial|Myoepithelial tumour|Myoepithelial Tumor | Myoepithelioma |
C0206625 | A malignant tumor composed of more than one type of neoplastic tissue. (Dorland, 27th ed) | Mixed Tumor, Malignant|Mixed tumor, malignant|Malignant Mixed Neoplasm|Mixed tumour, malignant|Malignant Mixed Tumors|Mixed Tumors, Malignant|Mixed tumour, malignant, NOS|Mixed tumor, malignant, NOS|Malignant mixed tumour|Tumors, Malignant Mixed|Tumor, Malignant Mixed|Malignant mixed tumor|TUMOR, MIXED, MALIGNANT|Mixed tumor, malignant (morphologic abnormality)|Malignant Mixed Tumor | Malignant Mixed Tumor |
C0206656 | A form of RHABDOMYOSARCOMA arising primarily in the head and neck, especially the orbit, of children below the age of 10. The cells are smaller than those of other rhabdomyosarcomas and are of two basic cell types: spindle cells and round cells. This cancer is highly sensitive to chemotherapy and has a high cure rate with multi-modality therapy. (From Holland et al., Cancer Medicine, 3d ed, p2188) | Embryonal Rhabdomyosarcomas|Rhabdomyosarcoma, Embryonal|embryonal rhabdomyosarcoma|Embryonal rhabdomyosarcoma (disorder)|Embryonal rhabdomyosarcoma|Embryonal rhabdomyosarcoma (morphologic abnormality)|Embryonal Rhabdomyosarcoma|Rhabdomyosarcomas, Embryonal|ERMS | Embryonal Rhabdomyosarcoma |
C0334459 | A fibrosarcoma that occurs in infants. It shares identical morphologic features with adult fibrosarcoma but carries the t(12;15)(p13;q25) translocation that results in ETV6-NTRK3 gene fusion. It usually affects the superficial and deep soft tissues of the extremities. The prognosis is generally much more favorable than for adult fibrosarcoma, and it rarely metastasizes. | Infantile Fibrosarcoma|congenital fibrosarcoma|Congenital Fibrosarcoma|Infantile fibrosarcoma (morphologic abnormality)|Congenital fibrosarcoma|Infantile fibrosarcoma (disorder)|infantile fibrosarcoma|Infantile fibrosarcoma (congenital fibrosarcoma)|Infantile fibrosarcoma | Infantile fibrosarcoma |
C0855073 | An aggressive malignant mesenchymal neoplasm that arises from the liver and usually occurs in older children. It is composed of immature spindle, stellate, polymorphous, and giant cells. | SARCOMA, UNDIFFERENTIATED, MALIGNANT|Embryonal sarcoma|Undifferentiated Sarcoma|Embryonal Sarcoma|Undifferentiated (Embryonal) Sarcoma|Embryonal sarcoma (morphologic abnormality)|UES|Embryonal Sarcoma, Undifferentiated|undifferentiated sarcoma|Embryonal Sarcoma (Undifferentiated Sarcoma)|Undifferentiated sarcoma (morphologic abnormality)|Undifferentiated sarcoma | Undifferentiated (Embryonal) Sarcoma |
C0346010 | Autosomal dominant neoplastic syndrome characterised by genodermatosis, lung cysts, spontaneous and recurrent PNEUMOTHORAX; and RENAL CANCER. It is associated with mutations in the folliculin protein gene (FLCN protein). | Birt Hogg Dube Syndrome|Hornstein-Birt-Hogg-Dubé Syndrome|multiple fibrofolliculomas|Birt-Hogg-Dube Syndrome|BHD|HORNSTEIN-KNICKENBERG SYNDROME|Birt-Hogg-Dube syndrome|Fibrofolliculomas with Trichodiscomas and Acrochordons|FIBROFOLLICULOMAS WITH TRICHODISCOMAS AND ACROCHORDONS|Hornstein-Knickenberg Syndrome|Multiple fibrofolliculomas (disorder)|Multiple fibrofolliculomata|Multiple fibrofolliculomas|birt hogg dube syndrome|BIRT-HOGG-DUBE SYNDROME|birt-hogg-dube syndrome|Birt-Hogg-Dubé Syndrome|Birt-Hogg-Dubé syndrome|Familial multiple fibrofolliculoma | Multiple fibrofolliculomas |
C0751674 | A multifocal neoplasm with perivascular epithelioid cell differentiation affecting almost exclusively females of child-bearing age. It is characterized by the presence of smooth muscle and epithelioid cells and by the proliferation of lymphatic vessels. Sites of involvement include the lungs, mediastinum, and the retroperitoneum. It usually presents with chylous pleural effusion or ascites. | LYMPHANGIOMYOMATOSIS|Lymphangioleiomyomatoses|lymphangiomyomatosis|LYMPHANGIOLEIOMYOMATOSIS|Lymphangiomyomatosis (morphologic abnormality)|lymphangioleiomyomatosis|Lymphangiomyomatoses|Lymphangioleiomyomatosis|LAM|Lymphangiomyomatosis | Lymphangioleiomyomatosis |
C0219510 | A type I keratin expressed predominately in gastrointestinal epithelia, MERKEL CELLS, and the TASTE BUDS of the oral mucosa. | Keratin 20|Cytokeratin-20|Cytokeratin 20|Cytokeratin 20 (substance)|Keratin-20 | cytokeratin 20 |
C0262613 | An abnormal growth in the kidney. | kidney mass|Kidney Mass|Renal Mass|kidney masses|Renal mass (finding)|mass kidney|mass renal|kidneys mass|Kidney mass|RENAL MASS|renal mass|masses renal|KIDNEY MASS | Renal mass |
C0040479 | A malignant form of polymorphic ventricular tachycardia that is characterized by HEART RATE between 200 and 250 beats per minute, and QRS complexes with changing amplitude and twisting of the points. The term also describes the syndrome of tachycardia with prolonged ventricular repolarization, long QT intervals exceeding 500 milliseconds or BRADYCARDIA. Torsades de pointes may be self-limited or may progress to VENTRICULAR FIBRILLATION. | Torsades-de-Pointes|des pointes torsades|Ventricular tachycardia, polymorphic with Q-T prolongation|torsade de pointes|torsades de pointes|Torsades de Pointes|de Pointes, Torsade|des pointes torsade|TORSADES DE POINTES|Twisting spikes|de Pointes, Torsades|torsade de pointe|Ventricular tachycardia, torsades de pointes|des pointe torsade|de pointe torsades|Torsades de pointes (disorder)|Pointes, Torsade de|Torsades de pointes|Torsades De Pointes by ECG Finding|Torsade de Pointes|Pointes, Torsades de|Torsade de pointes|Torsades De Pointes|Torsades De Pointes by EKG Finding | Torsades de Pointes |
C0271791 | null | Severe hypothyroidism|Severe hypothyroidism (disorder) | Severe hypothyroidism |
C0027145 | A condition characterized by a dry, waxy type of swelling (EDEMA) with abnormal deposits of MUCOPOLYSACCHARIDES in the SKIN and other tissues. It is caused by a deficiency of THYROID HORMONES. The skin becomes puffy around the eyes and on the cheeks. The face is dull and expressionless with thickened nose and lips. | Myxedema (disorder)|Myxoedema|myxedema|myxoedema|Myxedemas|Myxoedema, NOS|MYXEDEMA|Myxedema, NOS|Myxedema|Mucin in skin|MYXOEDEMA | Myxedema |
C0085077 | Condition characterized by large, rapidly extending, erythematous, tender plaques on the upper body usually accompanied by fever and dermal infiltration of neutrophilic leukocytes. It occurs mostly in middle-aged women, is often preceded by an upper respiratory infection, and clinically resembles ERYTHEMA MULTIFORME. Sweet syndrome is associated with LEUKEMIA. | Sweet's Syndrome|SS|SWEET SYNDROME|Acute febrile neutrophilic dermatosis|Acute febrile neutrophilic dermatosis (disorder)|sweet's syndrome|Syndrome, Sweet|sweet's disease|Syndrome, Sweet's|Disease, Gomm Button|Sweet Syndrome|NEUTROPHILIC DERMATOSIS, ACUTE FEBRILE|febrile neutrophilic dermatosis|Gomm Button Disease|AFND|Neutrophilic Dermatosis, Acute Febrile|Sweet syndrome|Acute Febrile Neutrophilic Dermatosis|Sweet's syndrome|Sweets Syndrome|SWEET'S SYNDROME|Febrile neutrophilic dermatosis|Dermatosis, Neutrophilic, Febrile, Acute|Gomm-Button Disease|Disease, Gomm-Button|Sweet disease|sweet syndrome|sweets syndrome|GOMM-BUTTON DISEASE|Sweet's disease | Sweet Syndrome |
C0239573 | null | high grade fever|FEVER, HIGH GRADE|fever grade high|FEVER, HIGHGRADE | Fever, high-grade |
C0264490 | Life-threatening respiratory failure that develops rapidly. Causes include injury, sepsis, drug overdose, and pancreatitis. It manifests with dyspnea and cyanosis and may lead to cardiovascular shock. | arf|Acute respiratory failure|ARF - Acute respiratory failure|Acute respiratory failure (disorder)|Respiratory failure, acute|acute respiratory failure|Acute Respiratory Failure|acute failure respiratory | Acute respiratory failure |
C0265122 | <p>The pericardium is a membrane, or sac, that surrounds your heart. It holds the heart in place and helps it work properly. Problems with the pericardium include</p> <ul> <li>Pericarditis - an inflammation of the sac. It can be from a virus or other infection, a heart attack, heart surgery, other medical conditions, injuries, and certain medicines.</li> <li>Pericardial effusion - the buildup of fluid in the sac</li> <li>Cardiac tamponade - a serious problem in which buildup of fluid in the sac causes problems with the function of the heart</li> </ul> <p>Symptoms of pericardial problems include chest pain, rapid heartbeat, and difficulty breathing. Fever is a common symptom of acute pericarditis. Your doctor may use a physical exam, imaging tests, and heart tests to make a diagnosis. Treatment depends on the cause.</p> <p class="">NIH: National Heart, Lung, and Blood Institute</p> | pericardial disease|Pericardial disease or syndrome|Disorder of pericardium (disorder)|Disorder of pericardium|diseases pericardium|PERICARDIAL DISEASES: GENERAL CONDITIONS|Pericardial Disorders|Pericardial disorder, NOS|Pericardial Diseases and Syndromes|Disease of pericardium, NOS|Unspecified disease of pericardium|Pericardial disorder|PERICARDIAL DISEASES|pericardial diseases | Disorder of pericardium |
C0280274 | Treatment of viral infections with agents that prevent viral replication in infected cells without impairing the host cell function. | Treatment of Infectious Diseases, Viral|Infectious Diseases / Treatment, Viral|treatment of viral infectious disease|antiviral therapy|Antiviral therapy|Antiviral Therapy|Antiviral therapy (procedure)|therapy, antiviral | Antiviral Therapy |
C0239946 | The presence of excessive fibrous connective tissue in the liver. Fibrosis is a reparative or reactive process. [HPO:probinson] | liver fibroses|Hepatic fibrosis|fibrosis of liver|liver fibrosis|HEPATIC FIBROSIS|Hepatic fibrosis, NOS|hepatic fibrosis|Liver Fibrosis|fibrosis hepatic|Liver fibrosis|Fibrosis of liver|fibrosis liver|Hepatic fibrosis (disorder)|FIBROSIS LIVER | Fibrosis, Liver |
C0341439 | Hepatic necrosis, inflammation, or scarring due to any cause that persists for more than 6 months. Manifestations may include signs and symptoms of cholestasis, portal hypertension, and/or abnormal liver function tests. | chronic disease liver|HEPATIC: CHRONIC|Chronic hepatopathy|chronic hepatic|liver disease chronic|chronic diseases liver|chronic liver disease|Chronic liver disease (disorder)|Chronic Liver Disease | Chronic liver disease |
C0013103 | The removal of fluids or discharges from the body, such as from a wound, sore, or cavity. | Drainage|Drainage procedure (procedure)|Drainage - action (qualifier value)|drainage action|Drainage - action|drain|drainage procedure|Drainage procedure | Drainage procedure |
C0206669 | A benign epithelial tumor of the LIVER. | Liver Cell Adenoma|Adenomas, Liver Cell|Liver cell adenoma|Liver adenomas|Hepatomas, Benign|Benign hepatoma|HCA - Hepatocellular adenoma|Adenoma, Liver Cell|Adenoma, Hepatocellular|ADENOMA LIVER|ADENOMA, HEPATOCELLULAR, BENIGN|HCA|hepatocellular adenoma|Hepatoma, benign|Hepatoma, Benign|liver cell adenoma|Adenoma of liver|Adenoma of the Liver Cells|Liver cell adenoma (morphologic abnormality)|Adenomas, Hepatocellular|Adenoma of Liver Cells|hepatic adenoma|HEPATOCELLULAR ADENOMA <S>|hepatocellular adenomas|Benign Hepatoma|Hepatic adenoma|adenomas liver|liver adenoma|Hepatocellular Adenomas|Liver Cell Adenomas|adenomas hepatic|HEPATOCELLULAR ADENOMA|Hepatocellular Adenoma|Hepatocellular adenoma|Benign Hepatomas|adenoma liver|Adenoma of liver (disorder) | Hepatocellular Adenoma |
C0740651 | null | abdominal symptoms|abdominal symptom | Abdominal symptom |
C0878094 | null | Histacryls|Histoacryls|Histoacryl | Histacryl |
C0016522 | A condition in which the FORAMEN OVALE in the ATRIAL SEPTUM fails to close shortly after birth. This results in abnormal communications between the two upper chambers of the heart. An isolated patent ovale foramen without other structural heart defects is usually of no hemodynamic significance. | PFO - Patent foramen ovale|patent foraman ovale|FORAMEN OVALE PATENT|secundum atrial septal defect|Patent Foramen Ovale|Patent foramen ovale|patent foramen ovale|Patent foramen ovale (disorder)|Patent Oval Foramen|FORAMEN OVALE, PATENT|foramen ovale patent|patent foramen ovales|Foramen Ovale, Patent|Oval Foramen, Patent | Foramen Ovale, Patent |
C0007780 | null | Embolism, Cerebral|cerebral embolus|Cerebral embolism (disorder)|cerebral artery embolism|cerebral embolism|Cerebral arterial embolism|EMBOLISM, CEREBRAL|cerebral embolisms|EMBOLUS CEREBRAL|CEREBRAL EMBOLISM|Cerebral embolism|EMBOLISM CEREBRAL|Cerebral Emboli|Cerebral Embolus|Embolus, Cerebral|Emboli, Cerebral|cerebral emboli|arteries cerebral embolism | Cerebral Embolism |
C0017195 | Endoscopic examination, therapy or surgery of the interior of the stomach. | Endoscopy of stomach, NOS|Gastroscopies|Gastroscopy, NOS|gastroscopy|endoscopy stomach|Gastroscopy|STOMACH: ENDOSCOPY|Endoscopy of stomach (procedure)|upper endoscopy|Endoscopy of stomach | Endoscopy of stomach |
C0127615 | An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed) | mesalazine|Product containing mesalazine (medicinal product)|Mesalazine (substance)|5-aminosalicylic acid|5-Amino-2-hydroxybenzoic Acid|Mesalazine-containing product|m-Aminosalicylic acid|meta-Aminosalicylic Acid|5 Aminosalicylic Acid|Mesalamine|meta Aminosalicylic Acid|MESALAMINE|5-Aminosalicylic Acid|asa 5|Mesalamine-containing product|Fisalamine|5-asa|Mesalazinum|m Aminosalicylic Acid|m-aminosalicylic acid|Mésalazine|3-carboxy-4-hydroxyaniline|Mesalazine|5-amino-2-hydroxybenzoic acid|5-Aminosalicylic acid|Mesalazina|m-Aminosalicylic Acid|mesalamine|5-ASA|5 asa | mesalamine |
C0267211 | A distinct vascular lesion in the PYLORIC ANTRUM that is characterized by tortuous dilated blood vessels (ectasia) radiating outward from the PYLORUS. The vessel pattern resembles the stripes on the surface of a watermelon. This lesion causes both acute and chronic GASTROINTESTINAL HEMORRHAGE. | Watermelon Stomach|Antral Vascular Ectasias|GAVE - Gastric antral vascular ectasia|Watermelon Stomachs|gastric antral vascular ectasia|Ectasias, Antral Vascular|Ectasia, Antral Vascular|antral ectasias gastric vascular|Watermelon stomach|watermelon stomach|Vascular ectasia of gastric antrum|Gastric Antral Vascular Ectasia|Stomach, Watermelon|Antral Vascular Ectasia|Vascular ectasia of gastric antrum (disorder)|Stomachs, Watermelon|Vascular Ectasias, Antral|Vascular Ectasia, Antral | Gastric Antral Vascular Ectasia |
C1527116 | Members of the various professions (e.g., PHYSICIANS) or occupations (e.g., POLICE). | Personnel|Occupational Groups|Worker|Workers|Occupational Group|Group, Occupational|Employee|Groups, Occupational|Employees | Workers |
C0032259 | A naturally radioactive element of the actinide metals series. It has the atomic symbol Pu, and atomic number 94. Plutonium is used as a nuclear fuel, to produce radioisotopes for research, in radionuclide batteries for pacemakers, and as the agent of fission in nuclear weapons. | Plutonium|Plutonium, NOS|Pu element|PLUTONIUM|Plutonium (substance)|plutonium | plutonium |
C0333606 | a degenerative disorder | Dystrophies|Dystrophy|Dystrophy, NOS|dystrophies|Dystrophy (morphologic abnormality)|dystrophy|DYSTROPHIES | Dystrophy |
C0007115 | A primary or metastatic malignant neoplasm affecting the thyroid gland. | Malignant Tumor of the Thyroid|THYROID NEOPLASM MALIGNANT|thyroid gland cancer|Malignant tumor of thyroid gland (disorder)|cancer of the thyroid|Thyroid cancer|Malignant Thyroid Tumor|Malignant neoplasm of thyroid gland|Malignant Thyroid Gland Neoplasm|Malignant Thyroid Neoplasm|Malignant Neoplasm of Thyroid|Malignant Tumor of Thyroid|thyroid cancer|Malignant Neoplasm of the Thyroid Gland|Thyroid Ca|Malignant Tumor of the Thyroid Gland|Malignant Neoplasm of Thyroid Gland|Malignant Thyroid Gland Tumor|Malignant tumor of thyroid gland|thyroid ca|Malignant Tumor of Thyroid Gland|Malignant Neoplasm of the Thyroid|Malignant tumour of thyroid gland|thyroid cancers|Cancer of thyroid | Malignant neoplasm of thyroid |
C0806909 | The largest possible quantity or degree. | Max (qualifier value)|Maximal|MAX|maximum|Maximum|Max|maxima | Maximum |
C0034553 | The spontaneous transformation of a nuclide into one or more different nuclides, accompanied by either the emission of particles from the nucleus, nuclear capture or ejection of orbital electrons, or fission. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) | radioactivities|Nuclear Decay|Radioactivity, NOS|Disintegration, Radioactive|Decay, Nuclear|Radioactivities|radioactivity|Radioactivity (physical force)|Radioactive|Disintegrations, Radioactive|Radioactive Disintegrations|Radioactive Disintegration|Radioactivity|radioactive | Radioactivity |
C0027945 | Activation analysis in which the specimen is bombarded with neutrons. Identification is made by measuring the resulting radioisotopes. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) | Activation Analysis, Neutron|Neutron Activation Analyses|Analysis, Neutron Activation|Analyses, Neutron Activation|Activation Analyses, Neutron|neutron activation analysis | Neutron Activation Analysis |
C0013502 | An infection caused by the infestation of the larval form of tapeworms of the genus Echinococcus. The liver, lungs, and kidney are the most common areas of infestation. | Hydatidosis|hydatidosis|disease hydatid|Infection, Echinococcus|cyst hydatid|ECHINOCOCCOSIS|hydatid cyst|Echinococciasis|hydatid disease|ECHINOCOCCIASIS|Echinococcus Infection|echinococcus disease|Hydatid disease|Echinococcus Infections|HYDATID DISEASE|echinococciasis|Echinococcus disease|echinococcosis|Echinococcosis|HYDATIDOSIS|Echinococcosis (disorder)|Echinococcoses | Echinococcosis |
C0040100 | A neoplasm originating from thymic tissue, usually benign, and frequently encapsulated. Although it is occasionally invasive, metastases are extremely rare. It consists of any type of thymic epithelial cell as well as lymphocytes that are usually abundant. Malignant lymphomas that involve the thymus, e.g., lymphosarcoma, Hodgkin's disease (previously termed granulomatous thymoma), should not be regarded as thymoma. (From Stedman, 25th ed) | THYMOMA|thymomas|Thymoma, no ICD-O subtype|Thymoma (disorder)|thymoma|Thymoma, no International Classification of Diseases for Oncology subtype|Thymoma|Thymoma, NOS|Thymoma, no International Classification of Diseases for Oncology subtype (morphologic abnormality)|Thymomas | Thymoma |
C0040115 | Enlargement of the thymus. A condition described in the late 1940's and 1950's as pathological thymic hypertrophy was status thymolymphaticus and was treated with radiotherapy. Unnecessary removal of the thymus was also practiced. It later became apparent that the thymus undergoes normal physiological hypertrophy, reaching a maximum at puberty and involuting thereafter. The concept of status thymolymphaticus has been abandoned. Thymus hyperplasia is present in two thirds of all patients with myasthenia gravis. (From Segen, Dictionary of Modern Medicine, 1992; Cecil Textbook of Medicine, 19th ed, p1486) | Hyperplasias, Thymic|Gland Hyperplasia, Thymus|Thymus Gland Hyperplasias|Thymic Hyperplasias|Hyperplasia of Thymus Gland|Hyperplasia, Thymus|Gland Hyperplasias, Thymus|thymus hyperplasia|Thymic hyperplasia|Thymus Gland Hyperplasia|Thymic Hyperplasia|hyperplasia thymus|Thymus hyperplasia|Hyperplasia, Thymic|Enlarged thymus | Thymus Hyperplasia |
C0040113 | A single, unpaired primary lymphoid organ situated in the MEDIASTINUM, extending superiorly into the neck to the lower edge of the THYROID GLAND and inferiorly to the fourth costal cartilage. It is necessary for normal development of immunologic function early in life. By puberty, it begins to involute and much of the tissue is replaced by fat. | Reticuloendothelial System, Thymus|Thymus gland structure|THYMUS GLAND|Gland, Thymus|Glands, Thymus|Thymus|THYMUS|thymus|Thymus, NOS|Thymus gland|Thymus gland structure (body structure)|Thymic|thymus glands|Thymus Glands|Thymus Gland|thymus gland | Thymus Gland |
C0040071 | Surgical removal of the thymus gland. (Dorland, 28th ed) | thymus removal|Total thymectomy|Thymectomies|thymectomy|Excision of thymus (procedure)|Thymectomy|Thymectomy, not otherwise specified|Excision of thymus | Thymectomy |
C0189557 | The production of adhesions between the parietal and visceral pleura. The procedure is used in the treatment of bronchopleural fistulas, malignant pleural effusions, and pneumothorax and often involves instillation of chemicals or other agents into the pleural space causing, in effect, a pleuritis that seals the air leak. (From Fishman, Pulmonary Diseases, 2d ed, p2233 & Dorland, 27th ed) | PLEURODESIS|Scarification of pleura|Pleurodesis|pleurodesis procedure|Pleurosclerosis|Pleurodesis (procedure)|Pleural cavity obliteration (procedure)|pleurodesis|Pleural cavity obliteration|Obliteration of pleural cavity|Pleurodesis, NOS | Pleurodesis |
C0080032 | Presence of fluid in the PLEURAL CAVITY as a complication of malignant disease. Malignant pleural effusions often contain actual malignant cells. | malignant effusion|Pleural Effusions, Malignant|pleural effusion malignant|Malignant effusion|malignant pleural effusions|effusion malignant|effusion malignant pleural|pleural effusion, malignant|effusion pleural malignant|Neoplastic pleural effusion|Malignant Pleural Effusion|Pleural effusion due to malignancy|Effusion, Malignant Pleural|Effusions, Malignant Pleural|Malignant pleural effusion|malignant pleural effusion|Malignant Pleural Effusions|Neoplastic pleural effusion (disorder) | Pleural Effusion, Malignant |
C0011980 | The musculofibrous partition that separates the THORACIC CAVITY from the ABDOMINAL CAVITY. Contraction of the diaphragm increases the volume of the thoracic cavity aiding INHALATION. | DIAPHRAGM|Diaphragm, Respiratory|Diaphragm|diaphragm|Diaphragm, NOS|Diaphragma|Diaphragmatic|MUSCLE, DIAPHRAGM|Diaphragm structure (body structure)|diaphragms|Thoracic diaphragm|Diaphragms|Diaphragm structure|Diaphragmatic (qualifier value)|Diaphragms, Respiratory|Respiratory Diaphragm|Respiratory Diaphragms | Respiratory Diaphragm |
C1279038 | null | Entire diaphragm (body structure)|Entire diaphragm | Entire diaphragm |
C0740844 | null | air fluid level|air fluid levels | AIR FLUID LEVEL (finding) |
C0008031 | Pressure, burning, or numbness in the chest. | pain thoracic|PAIN CHEST|Pains, Chest|CHEST PAIN|thoracalgia|Pain In Chest|Thorax painful|Chest pain, unspecified|thorax pain|Chest Pain|Thoracic pain|Chest Pains|Chest pain, NOS|thoracodynia|thoracic pain|chest pain|Pain, Chest|Chest pain (finding)|Chest pain|Nonspecific chest pain | Chest Pain |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.